Patents by Inventor Conrad Coester

Conrad Coester has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9504760
    Abstract: The present invention relates to a preferably nebulizable pharmaceutical composition comprising a pharmaceutically acceptable protein-based nanocarrier preferably in the size range 150 to 300 nm and a preventative or therapeutic amount of an active agent for use in the prevention and/or treatment of an allergic and/or inflammatory disease of the lower airways in a mammal. Preferably, the active agent is a CpG oligodeoxynucleotide (CpG-ODN), and preferably the composition exhibits a prolonged clinical effect.
    Type: Grant
    Filed: March 6, 2012
    Date of Patent: November 29, 2016
    Inventors: Sebastian Fuchs, Conrad Coester, Heidrun Gehlen, John Klier, Gerhard Winter
  • Publication number: 20120231041
    Abstract: The present invention relates to a preferably nebulizable pharmaceutical composition comprising a pharmaceutically acceptable protein-based nanocarrier preferably in the size range 150 to 300 nm and a preventative or therapeutic amount of an active agent for use in the prevention and/or treatment of an allergic and/or inflammatory disease of the lower airways in a mammal. Preferably, the active agent is a CpG oligodeoxynucleotide (CpG-ODN), and preferably the composition exhibits a prolonged clinical effect.
    Type: Application
    Filed: March 6, 2012
    Publication date: September 13, 2012
    Inventors: Sebastian Fuchs, Conrad Coester, Heidrun Gehlen, John Klier, Gerhard Winter
  • Publication number: 20080003292
    Abstract: Nanoparticles are disclosed, consisting essentially of an aqueous gelatin gel, wherein the average diameter of the nanoparticles is at the most 350 nm, the polydispersity index of the nanoparticles is less than or equal to 0.15 and wherein a gelatin is used as starting material for the production process. A process for the production of these nanoparticles is also disclosed.
    Type: Application
    Filed: February 16, 2007
    Publication date: January 3, 2008
    Applicant: GELITA AG
    Inventors: Michael AHLERS, Conrad COESTER, Klaus ZWIOREK, Jan ZILLIES
  • Publication number: 20070184068
    Abstract: The application is related to compositions and methods for the treatment of hypersensitivity, wherein the compositions comprise a particle packaged with immunostimulatory nucleic acids. The compositions of the invention are particularly useful in the treatment of atopic eczema, asthma and IgE-mediated allergy (type I allergy), especially pollen allergy and house dust allergy.
    Type: Application
    Filed: December 14, 2006
    Publication date: August 9, 2007
    Applicant: Cytos Biotechnology AG
    Inventors: Wolfgang Renner, Martin Bachmann, Indulis Cielens, Conrad Coester, Klaus Dietmeier, Sebastian Fuchs, Vania Manolova, Patrik Maurer, Paul Pumpens, Regina Renhofa, Alain Tissot, Yu Zou